Biotech Co. Sues Sandoz Over Remodulin Generic
United Therapeutics lodged a patent infringement suit in New Jersey federal court on Thursday seeking to stop Sandoz Inc. from launching a generic version of United Therapeutics' pulmonary arterial hypertension treatment...To view the full article, register now.
Already a subscriber? Click here to view full article